CXCL5 and neoplasm: The SCID/NOD mice were injected with neutrophils and CD8+ T cells via the tail vein, followed by weekly injections of either anti-CXCL5 antibody or anti-PD-L1 antibody injections over a 3-week period subsequent to tumor formation using the A549 cell line.